These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11060718)

  • 1. Ongoing trials in Alzheimer's disease.
    Sramek JJ; Cutler NR
    Expert Opin Investig Drugs; 2000 Apr; 9(4):899-915. PubMed ID: 11060718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in the drug treatment of Alzheimer's disease.
    Sramek JJ; Cutler NR
    Drugs Aging; 1999 May; 14(5):359-73. PubMed ID: 10408736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the next generation of Alzheimer's disease therapeutics: challenges for drug development.
    Cutler NR; Sramek JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Jan; 25(1):27-57. PubMed ID: 11263756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free radicals in Alzheimer's dementia: currently available therapeutic strategies.
    Rösler M; Retz W; Thome J; Riederer P
    J Neural Transm Suppl; 1998; 54():211-9. PubMed ID: 9850930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting monoamine oxidases with multipotent ligands: an emerging strategy in the search of new drugs against neurodegenerative diseases.
    Pisani L; Catto M; Leonetti F; Nicolotti O; Stefanachi A; Campagna F; Carotti A
    Curr Med Chem; 2011; 18(30):4568-87. PubMed ID: 21864289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review).
    Cai Z
    Mol Med Rep; 2014 May; 9(5):1533-41. PubMed ID: 24626484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future therapeutic approaches to Alzheimer's disease.
    Davis KL
    J Clin Psychiatry; 1998; 59 Suppl 11():14-6. PubMed ID: 9731545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current pharmacotherapies for Alzheimer's disease.
    Knopman DS
    Geriatrics; 1998 Sep; 53 Suppl 1():S31-4. PubMed ID: 9745634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of Alzheimer's disease].
    López OL; Becker JT
    Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-modifying therapies in Alzheimer's disease: how far have we come?
    Hüll M; Berger M; Heneka M
    Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.
    Cai P; Fang SQ; Yang XL; Wu JJ; Liu QH; Hong H; Wang XB; Kong LY
    ACS Chem Neurosci; 2017 Nov; 8(11):2496-2511. PubMed ID: 28806057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids.
    Bautista-Aguilera OM; Esteban G; Chioua M; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Soriano E; Samadi A; Unzeta M; Marco-Contelles J
    Drug Des Devel Ther; 2014; 8():1893-910. PubMed ID: 25378907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New therapeutic options in Alzheimer's disease].
    García-Ruiz Espiga PJ; Echeverría A; García-Torres A; Contreras A
    Rev Neurol; 2006 Apr 16-30; 42(8):478-81. PubMed ID: 16625510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel chelators targeting cell cycle arrest, acetylcholinesterase, and monoamine oxidase for Alzheimer's therapy.
    Zheng H; Fridkin M; Youdim MB
    Curr Drug Targets; 2012 Jul; 13(8):1089-106. PubMed ID: 22676912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alzheimer's disease: from brain lesions to new drugs].
    Forette F; Hauw JJ
    Bull Acad Natl Med; 2008 Feb; 192(2):363-78; discussion 378-80. PubMed ID: 18819689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive enhancement therapy for Alzheimer's disease. The way forward.
    Parnetti L; Senin U; Mecocci P
    Drugs; 1997 May; 53(5):752-68. PubMed ID: 9129864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for pharmacological intervention in Alzheimer disease.
    Emilien G; Beyreuther K; Masters CL; Maloteaux JM
    Arch Neurol; 2000 Apr; 57(4):454-9. PubMed ID: 10768617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in the management of Alzheimer's disease.
    Smith AL; Whitehouse PJ
    Hosp Pract (1995); 1998 Mar; 33(3):151-4, 157-66. PubMed ID: 9522840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives of pharmacotherapy in Alzheimer's disease.
    Yamada K; Ren X; Nabeshima T
    Jpn J Pharmacol; 1999 May; 80(1):9-14. PubMed ID: 10446751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.